Neutralising immunity to omicron sublineages BQ. 1.1, XBB, and XBB. 1.5 in healthy adults is boosted by bivalent BA. 1-containing mRNA vaccination and previous …
…, R Harvey, H Townsley, C Bailey, AS Fowler… - The Lancet Infectious …, 2023 - thelancet.com
During the autumn of 2022, both the US Centers for Disease Control and Prevention and
the UK’s Joint Committee on Vaccination and Immunisation recommended the targeted …
the UK’s Joint Committee on Vaccination and Immunisation recommended the targeted …
[HTML][HTML] Within-host SARS-CoV-2 viral kinetics informed by complex life course exposures reveals different intrinsic properties of Omicron and Delta variants
The emergence of successive SARS-CoV-2 variants of concern (VOC) during 2020-22, each
exhibiting increased epidemic growth relative to earlier circulating variants, has created a …
exhibiting increased epidemic growth relative to earlier circulating variants, has created a …
Emergence of new subgenomic mRNAs in SARS-CoV-2
…, M Crawford, DM Snell, AS Fowler, S Hussain… - bioRxiv, 2022 - biorxiv.org
Two mutations occurred in SARS-CoV-2 early during the COVID-19 pandemic that have
come to define circulating virus lineages 1 : first a change in the spike protein (D614G) that …
come to define circulating virus lineages 1 : first a change in the spike protein (D614G) that …
Combined analyses of within-host SARS-CoV-2 viral kinetics and information on past exposures to the virus in a human cohort identifies intrinsic differences of …
The emergence of successive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
variants of concern (VOCs) during 2020 to 2022, each exhibiting increased epidemic …
variants of concern (VOCs) during 2020 to 2022, each exhibiting increased epidemic …
Independent SARS-CoV-2 staff testing protected academic and health-care institutions in northwest London
An important component of the UK’s early response to the COVID-19 pandemic was increasing
SARS-CoV-2 testing capacity across the National Health Service (NHS). At the time, we …
SARS-CoV-2 testing capacity across the National Health Service (NHS). At the time, we …
COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA. 1, BA. 2, BA. 4/5 or Delta associates with similar illness duration …
Background SARS-CoV-2 variant Omicron rapidly evolved over 2022, causing three waves
of infection due to sub-variants BA.1, BA.2 and BA.4/5. We sought to characterise symptoms …
of infection due to sub-variants BA.1, BA.2 and BA.4/5. We sought to characterise symptoms …
SARS-CoV-2 mucosal neutralising immunity after vaccination
…, H Townsley, R Harvey, C Bailey, AS Fowler… - The Lancet Infectious …, 2024 - thelancet.com
Mucosal vaccines that prevent SARS-CoV-2 infection might provide benefits beyond existing
intramuscularly administered vaccines: through enhanced individual-level protection …
intramuscularly administered vaccines: through enhanced individual-level protection …
[HTML][HTML] Non-hospitalised, vaccinated adults with COVID-19 caused by Omicron BA. 1 and BA. 2 present with changing symptom profiles compared to those with Delta …
Introduction The impact of COVID-19 vaccination on disease in the community has been
limited, as a result of both SARS-CoV-2 Variants of Concern that partially escape vaccine-…
limited, as a result of both SARS-CoV-2 Variants of Concern that partially escape vaccine-…
COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA. 1, BA. 2, BA. 5 or Delta associates with similar illness duration, symptom …
Background SARS-CoV-2 variant Omicron rapidly evolved over 2022, causing three waves
of infection due to sub-variants BA.1, BA.2 and BA.4/5. We sought to characterise symptoms …
of infection due to sub-variants BA.1, BA.2 and BA.4/5. We sought to characterise symptoms …
Dichotomy of neutralizing antibody, B cell and T cell responses to SARS-CoV-2 vaccination and protection in healthy adults
…, M Ragno, LS Herman, R Harvey, C Bailey, AS Fowler… - bioRxiv, 2023 - biorxiv.org
Heterogeneity in SARS-CoV-2 vaccine responses is not understood. Here, we identify four
patterns of live-virus neutralizing antibody responses: individuals with hybrid immunity (with …
patterns of live-virus neutralizing antibody responses: individuals with hybrid immunity (with …
